Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661.TWO
Welgene Biotech Co.,Ltd.TW flagTaipei Exchange
18.55
TWD
- -
- -
432.29MMarket Cap

Welgene Biotech Co.,Ltd. (6661.TWO) Stock Split History

Learn about Welgene Biotech Co.,Ltd.'s most recent 27-for-25 basis stock split on August 17, 2018. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Welgene Biotech Co.,Ltd.'s most recent stock split

Split Date: 2018-08-17
Split Ratio: 27:25
Price Before Split: $22.17
Price After Split: $20.53

Developer API

Get 6661.TWO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/6661.TWO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.08 times more shares (a 27:25 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Welgene Biotech Co.,Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2018-08-1727:25No$22.17$20.53

About Welgene Biotech Co.,Ltd.

Company overview and industry information

Welgene Biotech Co.,Ltd. (6661.TWO) operates in the Medical - Diagnostics & Research industry. The recent 27-for-25 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Medical - Diagnostics & Research
Go to Welgene Biotech Co.,Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.